Why you should stop scrolling in the bathroom and the unsavory truth about your phone.

Published Date: 26 Apr 2023

More than 90% of people in the world own or use a mobile phone, and many of us couldn't live without them. We carry them everywhere we go, use them in bed and the bathroom, and for many people, they are the first thing they see in the morning.

Read Full News

Latest News

HIV Treatment May Move Beyond Daily Pills With Injectables

Monthly injectable HIV therapy shows lower treatment failure than oral regimens in individuals with adherence challenges.

Funding Cuts Challenge Malaria Vaccination Initiatives

Fewer resources through Gavi, the Vaccine Alliance, may limit vaccine administration at the local level.

Global Fund Expands Commitment to Improve Access to HIV Drug

The U.S. and the Global Fund to Fight AIDS, Tuberculosis and Malaria are stepping up efforts to ⁠broaden access to Gilead's HIV prevention drug, with a goal of reaching 3...

Trump Officials Consider Ophthalmologist Hemmati for Top Vaccine Post, Reports Say

The Trump administration is considering appointing Houman Hemmati, an ⁠ophthalmologist and a frequent Fox News guest, to lead the FDA's Center ⁠for Biologics Evaluation and...

Should US Policies Qualify as a Global Health Emergency?

Debate is growing over whether national policy decisions can meet the criteria for global health emergencies, as projections suggest major setbacks in infectious disease control.

US CDC Delays Publishing Report Showing COVID Vaccine Benefits, WaPo Reports

The acting director of ⁠the Centers for Disease Control ⁠and Prevention has delayed publication ⁠of a ‌CDC report showing the COVID-19 vaccine cut the likelihood of...

Todays Updates

Early Tislelizumab May Boost PFS in Esophageal Cancer

For patients with locally advanced esophageal cancer, front-loading immunotherapy with induction chemo and chemoradiotherapy, without maintenance immunotherapy, may improve outcomes.

ctDNA Predicts Relapse in Locally Advanced Cervical Cancer

Posttreatment ctDNA positivity correlates with worse relapse-free survival and earlier recurrence in patients with locally advanced cervical cancer, real-world data show.

GLP-1 RAs May Lower Hysterectomy Risk in Endometrial Cancer

There’s now a hint that GLP-1 receptor agonists might prevent hysterectomies in endometrial intraepithelial neoplasia/early-stage endometrial cancer, but prospective trials are needed to confirm it.

Todays Updates

Early Tislelizumab May Boost PFS in Esophageal Cancer

For patients with locally advanced esophageal cancer, front-loading immunotherapy with induction chemo and chemoradiotherapy, without maintenance immunotherapy, may improve outcomes.

ctDNA Predicts Relapse in Locally Advanced Cervical Cancer

Posttreatment ctDNA positivity correlates with worse relapse-free survival and earlier recurrence in patients with locally advanced cervical cancer, real-world data show.

GLP-1 RAs May Lower Hysterectomy Risk in Endometrial Cancer

There’s now a hint that GLP-1 receptor agonists might prevent hysterectomies in endometrial intraepithelial neoplasia/early-stage endometrial cancer, but prospective trials are needed to confirm it.

Latest News

Monthly injectable HIV therapy shows lower treatment failure than oral regimens in individuals with adherence challenges.

Fewer resources through Gavi, the Vaccine Alliance, may limit vaccine administration at the local level.

The U.S. and the Global Fund to Fight AIDS, Tuberculosis and Malaria are stepping up efforts to ⁠broaden access to Gilead's HIV prevention drug, with a goal of reaching 3...

The Trump administration is considering appointing Houman Hemmati, an ⁠ophthalmologist and a frequent Fox News guest, to lead the FDA's Center ⁠for Biologics Evaluation and...

Debate is growing over whether national policy decisions can meet the criteria for global health emergencies, as projections suggest major setbacks in infectious disease control.

The acting director of ⁠the Centers for Disease Control ⁠and Prevention has delayed publication ⁠of a ‌CDC report showing the COVID-19 vaccine cut the likelihood of...

News All Time

Is Integrase Inhibitor-Based HIV Therapy Safe in Pregnancy?

In utero exposure to integrase inhibitor-based antiretroviral regimens is not associated with adverse 1-year neurodevelopmental outcomes compared with exposure to other antiretroviral regimens.

Ryan White: The Safety Net We Cannot Afford to Shrink

Dr Daskalakis shares the important strides that HIV/AIDS care has made and how critical access to care can be for some patients.

Nigerian HIV Volunteers Went Door-to-Door Amid Aid Cuts

For several months last year, Josephine Angev walked the dusty village paths of Nigeria's Benue State to help people living with HIV stay on their life-saving medication.

Kennedy Allies Petition to Broaden US Vaccine Injury List

An anti-vaccine group aligned with U.S. Health Secretary Robert F. Kennedy Jr. is petitioning him to vastly broaden a federal list to include more than 300 injuries it says...

Kids Confirmed as Top Transmitters of RSV

New modeling data support targeted prevention efforts.

Kent Meningitis Outbreak Triggers Surge in UK Vaccine Demand, Policy Debate

Young people in southeast England and beyond are lining up for the meningitis B vaccine after an outbreak killed two people, sparking supply warnings from pharmacies and...

Parasitic Worms Provide Insights on RSV Prevention

Researchers identify metabolite alternatives to helminth-influenced protection.

Viral Coinfection May Predict Bacteremic Pneumonia

Patients with respiratory viral co-infection may have an increased risk of developing bacteremic Staphylococcus aureus pneumonia and 30-day mortality compared with those without viral co-infection.

UK Says Vaccine Protects Against Strain in Deadly Meningitis Outbreak

Britain's health authorities said on Friday that early laboratory analysis had shown the vaccine being ⁠offered to students should protect against the strain of meningitis...

Sudan Clinics Could Run Out of Supplies Due to Middle East War

Medical supplies to clinics dealing with the humanitarian crisis in Sudan could run out within 2 weeks unless ⁠shipments are rapidly rerouted.

Around 4.9 Million Children Under Five Died in 2024, Says UN

About 4.9 million children died before reaching their fifth birthday in 2024, according to new United Nations estimates, a sign progress ⁠to reduce child mortality rates was...

UK Races to Contain Meningitis Outbreak in Kent After Two Deaths

Britain will roll out meningitis vaccines to students at a university in southeast England after an "unprecedented" outbreak of the disease killed two people while the...

Treating Gonorrhea Orally: Access vs Resistance

Zoliflodacin and gepotidacin make oral therapy viable again for urogenital gonorrhea, yet lower pharyngeal efficacy and weak resistance surveillance mean clinicians must adopt cautious, targeted use.

Starting HIV PrEP in the Second Trimester Appears Safe

In pregnant women testing negative for HIV, second-trimester preexposure prophylaxis with the dapivirine vaginal ring or oral tenofovir disoproxil fumarate-emtricitabine is safe.

Drop in HIV/HCV Coinfections After Nationwide HCV Program

Following Iceland’s national hepatitis C elimination program, a substantial reduction was observed in the number of HIV/hepatitis C virus coinfections from 2016 to 2020.

Doctors Warn of a Deadly Complication From Measles Outbreaks

Measles causes complications — ranging from diarrhea to death — in 3 in 10 infected people, according to the Infectious Diseases Society of America.

Recommended News For You

AI tool accurately detects tumor location on breast MRI

GLP-1 Drugs Linked to Lower Colorectal Cancer Risk for Diabetes Patients.

In cases of locally advanced, potentially curable pancreatic cancer, a combination of drugs enhances the results of radiation therapy.

Too Many Kids With Sickle Cell Disease Aren't Getting Appropriate Preventive Care

More Support for Early Detection; Cancer in Men Rising; Diet Drives Colon Cancer

Clinical Evidence Shows Venetoclax Combo Is Safe and Effective in AML Patients 80 Years of Age and Up.

The need for more Latinx participants in Alzheimer's trials is urgent.

Recommended Articles For You

Unlocking the Secrets of Blood Production: The Journey and Regulation of Hematopoietic Stem Cells 

Tailoring the Immune Response: The Dawn of Personalized Vaccines in Cancer Immunotherapy 

Giant Sebaceous Cyst of the Scalp Mimicking a Soft Tissue Tumor: A Case Study 

Exploring the Unseen: Carcinoid Syndrome and its Impact on Quality of Life 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

EGFR Inhibitors for Lung Cancer Tied to Increased Keratitis Risk.

2.

Response Duration After Stopping Enfortumab Vedotin in Bladder Cancer

3.

In Hemophilia A and B, a Novel Monoclonal Antibody Reduces Bleeding.

4.

Sustained reduction found in prostate cancer mortality with prostate-specific antigen screening

5.

A paper strip test might enable the early detection of cancer.

1.

Obesity as a major risk factor for cancer

2.

Screening Strategies in Oncology: A Subspecialty Guide to Early Detection and Better Outcomes

3.

Hemophilia: Pathophysiology, Genetics, and Treatment Advances

4.

Case Study: Combining Targeted Therapy with Immunotherapy for Metastatic Melanoma

5.

Tumor Evolution: Signaling, Cancer Cell Plasticity, and Intratumor Heterogeneity

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Navigating the Complexities of Ph Negative ALL - Part XIV

2.

Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer

3.

Dacomitinib Case Presentation: Baseline Treatment and Current Status

4.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part IV

5.

Role of Nimotuzumab in Management of Nasopharyngeal Cancer


Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot